Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an openâlabel Phase II study
Chari, Ajai, RodriguezâOtero, Paula, McCarthy, Helen, Suzuki, Kenshi, Hungria, Vania, Sureda Balari, Anna, Perrot, Aurore, Hulin, Cyrille, Magen, Hila, Iida, Shinsuke, Maisnar, Vladimir, Karlin, LioЖурнал:
British Journal of Haematology
DOI:
10.1111/bjh.16980
Date:
July, 2020
Файл:
PDF, 328 KB
2020
File converter
Більше результатів пошуку
More benefits 
